Stryker (FRA:SYK) Common Stock : €36 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Stryker Common Stock?

Stryker's quarterly common stock declined from Jun. 2024 (€35 Mil) to Sep. 2024 (€34 Mil) but then increased from Sep. 2024 (€34 Mil) to Dec. 2024 (€36 Mil).

Stryker's annual common stock declined from Dec. 2022 (€36 Mil) to Dec. 2023 (€35 Mil) but then increased from Dec. 2023 (€35 Mil) to Dec. 2024 (€36 Mil).

Stryker Common Stock Historical Data

The historical data trend for Stryker's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Common Stock Chart

Stryker Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

31.24

33.63

35.87

34.85

36.29

Stryker Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															34.85	34.96	35.30	34.24	36.29

Stryker Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Stryker Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (FRA:SYK) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

SYK:USA SYK:Mexico 1SYK:Italy 0R2S:UK SYK:Germany S1YK34:Brazil SYK:Austria

Address

1941 Stryker Way, Portage, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.